Institution
Università Campus Bio-Medico
Education•Rome, Italy•
About: Università Campus Bio-Medico is a education organization based out in Rome, Italy. It is known for research contribution in the topics: Population & Medicine. The organization has 2829 authors who have published 8519 publications receiving 193689 citations. The organization is also known as: Universita Campus Bio-Medico & Campus Bio-Medico University.
Topics: Population, Medicine, Cancer, Diabetes mellitus, Breast cancer
Papers published on a yearly basis
Papers
More filters
••
TL;DR: A new class of β-lactam derivatives that are potent, selective, and systemically active inhibitors of intracellular NAAA activity are described and may be used to probe the functions of NAAA in health and disease and as a starting point to discover better anti-inflammatory drugs.
Abstract: Fatty acid ethanolamides such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are lipid-derived mediators that potently inhibit pain and inflammation by ligating type-α peroxisome proliferator-activated receptors (PPAR-α). These bioactive substances are preferentially degraded by the cysteine hydrolase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages. Here, we describe a new class of β-lactam derivatives that are potent, selective, and systemically active inhibitors of intracellular NAAA activity. The prototype of this class deactivates NAAA by covalently binding the enzyme's catalytic cysteine and exerts profound anti-inflammatory effects in both mouse models and human macrophages. This agent may be used to probe the functions of NAAA in health and disease and as a starting point to discover better anti-inflammatory drugs.
64 citations
••
TL;DR: This study suggests that CDKN2A, in addition to BAP1, could be involved in the melanoma and mesothelioma susceptibility, leading to the rare familial cancer syndromes.
64 citations
••
TL;DR: The data demonstrate that PRP addition is not detrimental to the viscosupplementation effect of HA, and four different HA concentrations when combined with PRP are investigated giving insights on viscoelastic and biological properties of a promising approach for future OA therapy.
Abstract: Introduction
Osteoarthritis (OA) is the most common musculoskeletal disease. Current treatments for OA are mainly symptomatic and inadequate since none results in restoration of fully functional cartilage. Hyaluronic Acid (HA) intra-articular injections are widely accepted for the treatment of pain associated to OA. The goal of HA viscosupplementation is to reduce pain and improve viscoelasticity of synovial fluid. Platelet-rich plasma (PRP) has been also employed to treat OA to possibly induce cartilage regeneration. The combination of HA and PRP could supply many advantages for tissue repair. Indeed, it conjugates HA viscosupplementation with PRP regenerative properties. The aim of this study was to evaluate the rheological and biological properties of different HA compositions in combination with PRP in order to identify (i) the viscoelastic features of the HA-PRP blends, (ii) their biological effect on osteoarthritic chondrocytes and (iii) HA formulations suitable for use in combination with PRP.
64 citations
••
TL;DR: MS mRNA levels were significantly lower in autistic subjects, especially at younger ages, and this decrease was replicated in cultured human neuronal cells by treatment with TNF-α, whose CSF levels are elevated in autism.
Abstract: The folate and vitamin B12-dependent enzyme methionine synthase (MS) is highly sensitive to cellular oxidative status, and lower MS activity increases production of the antioxidant glutathione, while simultaneously decreasing more than 200 methylation reactions, broadly affecting metabolic activity. MS mRNA levels in postmortem human cortex from subjects across the lifespan were measured and a dramatic progressive biphasic decrease of more than 400-fold from 28 weeks of gestation to 84 years was observed. Further analysis revealed alternative splicing of MS mRNA, including deletion of folate-binding domain exons and age-dependent deletion of exons from the cap domain, which protects vitamin B12 (cobalamin) from oxidation. Although three species of MS were evident at the protein level, corresponding to full-length and alternatively spliced mRNA transcripts, decreasing mRNA levels across the lifespan were not associated with significant changes in MS protein or methionine levels. MS mRNA levels were significantly lower in autistic subjects, especially at younger ages, and this decrease was replicated in cultured human neuronal cells by treatment with TNF-α, whose CSF levels are elevated in autism. These novel findings suggest that rather than serving as a housekeeping enzyme, MS has a broad and dynamic role in coordinating metabolism in the brain during development and aging. Factors adversely affecting MS activity, such as oxidative stress, can be a source of risk for neurological disorders across the lifespan via their impact on methylation reactions, including epigenetic regulation of gene expression.
64 citations
••
TL;DR: There continues to be an ever‐expanding number of clinical studies investigating systemic therapies for MPM, and new insight into the molecular pathogenesis and the immunological tumor microenvironment of MPM is highlighting new potential therapeutic strategies.
64 citations
Authors
Showing all 2872 results
Name | H-index | Papers | Citations |
---|---|---|---|
Robert J. Motzer | 121 | 883 | 80129 |
Nicola Maffulli | 115 | 1570 | 59548 |
Bernard Escudier | 96 | 664 | 53523 |
Paolo Maria Rossini | 94 | 680 | 43935 |
Franco Mandelli | 89 | 720 | 33262 |
Matteo Cesari | 88 | 611 | 35197 |
Ana M. Valdes | 84 | 334 | 26627 |
Mauro Maccarrone | 80 | 533 | 22514 |
Patrizio Pasqualetti | 75 | 321 | 17042 |
Tiziana Bisogno | 75 | 130 | 19445 |
Massimo Inguscio | 74 | 427 | 21507 |
Guido Costamagna | 72 | 656 | 19050 |
Alberto Zangrillo | 70 | 539 | 21474 |
Antonio Abbate | 70 | 507 | 17365 |
Giovanni Landoni | 69 | 611 | 17481 |